Insights

Dr Moss, from Boston University, reviewed 3 key steps in optimizing care for patients with luminal Crohn disease during his presentation at the Advances in Regional Bowel Diseases regional meeting.

Dr Ha, from Mayo Clinic-Arizona, review the steps to properly diagnose stricturing Crohn disease and considerations in choosing and positioning therapies.

In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk to Dr Parambir Dulai about abstracts from the ECCO ’23 Congress on the role of biomarkers in the clinical care and research for inflammatory bowel disease.

Dr Hyman explains how surgery can be a highly efficacious option for first-line therapy of penetrating Crohn disease.

Dr Salwen-Deremer discusses some findings of her research into insomnia and sleep disturbance in inflammatory bowel disease, and how cognitive behavioral therapy can help.

Dr Kappelman reviews the results of the COMBINE trial, in which the efficacy of combined therapy using antitumor necrosis factor therapies with low-dose methotrexate was compared to anti-TNF monotherapy in pediatric patients with inflammatory...

Dr Rubin discusses his address from Digestive Disease Week 2023 in which he looks to the future of inflammatory disease therapy and advances in the field that include combination therapy, head-to-head drug trials, new therapies and more that...

Dr Melmed, from Cedars-Sinai Medical Center in Los Angeles, reviewed how to implement successful, practical quality improvements to the practice of gastroenterology to optimize outcomes among patients with inflammatory bowel disease.

Dr Barnes reviews key abstracts from ECCO 2023 on novel therapeutics for inflammatory bowel disease with hosts Drs Raymond Cross and Millie Long.

At the April 30 virtual regional meeting of Advances in Inflammatory Bowel Diseases, Dr Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center, discussed key steps gastroenterologists can take to help ensure their patients...